50
Participants
Start Date
June 4, 2019
Primary Completion Date
November 30, 2019
Study Completion Date
December 31, 2019
ABC/3TC/LPV/r granules (30/15/40/10 mgs)
"This is a fixed dose combination. Each capsule contains Lopinavir (40mg), Ritonavir (10mg), Abacavir (30mg) and Lamivudine (15mg) in granules formulation.~Dosage according to patient's weight:~Between 3 and 5.9kg: 2 capsules twice a day Between 6 and 9.9kg: 3 capsules twice a day Between 10 and 13.9kg: 4 capsules twice a day Between 14 and 19.9kg: 5 capsules twice a day Between 20 and 24.9kg: 6 capsules twice a day"
LPV/r Pellets (40/10mgs) plus ABC/3TC (60/30mgs)
"Lopinavir/Ritonavir (40/10mg pellets) plus dual Abacavir/Lamivudine (60/30mg dispersible tablets)~Dosage according to patient's weight:~LPV/r Pellets:~Between 3 and 5.9kg: 2 capsules twice a day Between 6 and 9.9kg: 3 capsules twice a day Between 10 and 13.9kg: 4 capsules twice a day Between 14 and 19.9kg: 5 capsules twice a day Between 20 and 24.9kg: 6 capsules twice a day~ABC/3TC:~Between 3 and 5.9kg: 1 tablet twice a day Between 6 and 9.9kg: 1.5 tablets twice a day Between 10 and 13.9kg: 2 tablets twice a day Between 14 and 19.9kg: 2.5 tablets twice a day Between 20 and 24.9kg: 3 tablets twice a day"
RECRUITING
Baylor College of Medicine Children's Foundation Uganda, Kampala
RECRUITING
Joint Clinical research Centre, Kampala
RECRUITING
Epicentre Mbarara Research Centre, Mbarara
Collaborators (1)
UNITAID
OTHER
AMS-PHPT Research Platform (Program for HIV Prevention and Treatment)
UNKNOWN
Joint Clinical Research Centre- Kampala
UNKNOWN
Baylor College of Medicine Childrens Foundation, Uganda
UNKNOWN
Epcentre Centre Mbarara Research Centre
UNKNOWN
Institute of Tropical Medicine, Belgium
OTHER
Drugs for Neglected Diseases
OTHER